Literature DB >> 17145063

One-step separation and purification of 3,4-dihydroxyphenyllactic acid, salvianolic acid B and protocatechualdehyde from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography.

Ming Gu1, Xiaolei Wang, Zhiguo Su, Fan Ouyang.   

Abstract

Three kinds of polyphenols of Salvia miltiorrhiza Bunge, 3,4-dihydroxyphenyllactic acid, salvianolic acid B and protocatechualdehyde, were separated and purified in one step with solvent system n-hexane-ethyl acetate-methanol-acetic acid-water (1:6:1.5:1.5:8) by high-speed counter-current chromatography. Acetic acid was successfully used to increase the partition of high polar target compounds in organic phase to modify partition coefficient value. 3,4-Dihydroxyphenyllactic acid, salvianolic acid B and protocatechualdehyde were purified from 100mg water extracted crude sample of Salvia miltiorrhiza Bunge at purity of 97.6%, 94.2% and 98.2% and at yield of 98.6%, 73.6% and 90.2%. High-speed counter-current chromatography together with organic/aqueous solvent system supplied an efficient method to purify water-soluble compounds directly from crude samples of traditional Chinese medicines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145063     DOI: 10.1016/j.chroma.2006.11.057

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Green Synthesis of Silver Nanoparticles Using Extract of Jasminum officinal L. Leaves and Evaluation of Cytotoxic Activity Towards Bladder (5637) and Breast Cancer (MCF-7) Cell Lines.

Authors:  Samir Osman; Mohamed El-Raey; Seham Elhawary; Hala El-Hefnawy; Fatma Alzahraa Mokhtar; Mansour Sobeh; Eman Mostafa
Journal:  Int J Nanomedicine       Date:  2020-12-04

Review 2.  Chinese Herbal Medicine Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating Endoplasmic Reticulum Stress.

Authors:  Wu-Lin Liang; Meng-Ru Cai; Ming-Qian Zhang; Shuang Cui; Tian-Rui Zhang; Wen-Hao Cheng; Yong-Hong Wu; Wen-Jing Ou; Zhan-Hong Jia; Shuo-Feng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-07       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.